Jensen MB - Search Results

1

Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer.

Celik A, Berg T, Jensen MB, Jakobsen E, Nielsen HM, Kümler I, Glavicic V, Jensen JD, Knoop A. Celik A, et al. Among authors: jensen mb, jensen jd. Breast Cancer (Auckl). 2023 Oct 4;17:11782234231203292. doi: 10.1177/11782234231203292. eCollection 2023. Breast Cancer (Auckl). 2023. PMID: 37810797 Free PMC article.

2

YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer.

Roslind A, Knoop AS, Jensen MB, Johansen JS, Nielsen DL, Price PA, Balslev E. Roslind A, et al. Among authors: jensen mb. Breast Cancer Res Treat. 2008 Nov;112(2):275-85. doi: 10.1007/s10549-007-9870-7. Epub 2007 Dec 22. Breast Cancer Res Treat. 2008. PMID: 18157633

3

DBCG trial 89B comparing adjuvant CMF and ovarian ablation: similar outcome for eligible but non-enrolled and randomized breast cancer patients.

Ejlertsen B, Jensen MB, Mouridsen HT, Andersen J, Cold S, Jakobsen E, Kamby C, Sørensen PG, Ewertz M. Ejlertsen B, et al. Among authors: jensen mb. Acta Oncol. 2008;47(4):709-17. doi: 10.1080/02841860802001475. Acta Oncol. 2008. PMID: 18465339 Clinical Trial.

4

HER2, TOP2A, and TIMP-1 and responsiveness to adjuvant anthracycline-containing chemotherapy in high-risk breast cancer patients.

Ejlertsen B, Jensen MB, Nielsen KV, Balslev E, Rasmussen BB, Willemoe GL, Hertel PB, Knoop AS, Mouridsen HT, Brünner N. Ejlertsen B, et al. Among authors: jensen mb. J Clin Oncol. 2010 Feb 20;28(6):984-90. doi: 10.1200/JCO.2009.24.1166. Epub 2009 Dec 28. J Clin Oncol. 2010. PMID: 20038724 Clinical Trial.

5

Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer.

Ejlertsen B, Mouridsen HT, Jensen MB, Andersen J, Andersson M, Kamby C, Knoop AS; Danish Breast Cancer Cooperative Group. Ejlertsen B, et al. Among authors: jensen mb. Cancer. 2010 May 1;116(9):2081-9. doi: 10.1002/cncr.24969. Cancer. 2010. PMID: 20186830 Free article. Clinical Trial.

6

CEF is superior to CMF for tumours with TOP2A aberrations: a Subpopulation Treatment Effect Pattern Plot (STEPP) analysis on Danish Breast Cancer Cooperative Group Study 89D.

Gunnarsdóttir KA, Jensen MB, Zahrieh D, Gelber RD, Knoop A, Bonetti M, Mouridsen H, Ejlertsen B. Gunnarsdóttir KA, et al. Among authors: jensen mb. Breast Cancer Res Treat. 2010 Aug;123(1):163-9. doi: 10.1007/s10549-010-0931-y. Epub 2010 May 13. Breast Cancer Res Treat. 2010. PMID: 20464479 Free PMC article.

7

Effect of obesity on prognosis after early-stage breast cancer.

Ewertz M, Jensen MB, Gunnarsdóttir KÁ, Højris I, Jakobsen EH, Nielsen D, Stenbygaard LE, Tange UB, Cold S. Ewertz M, et al. Among authors: jensen mb. J Clin Oncol. 2011 Jan 1;29(1):25-31. doi: 10.1200/JCO.2010.29.7614. Epub 2010 Nov 29. J Clin Oncol. 2011. PMID: 21115856

8

Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status.

Nielsen KV, Ejlertsen B, Møller S, Jensen MB, Balslev E, Müller S, Knoop A, Mouridsen HT. Nielsen KV, et al. Among authors: jensen mb. Mol Oncol. 2012 Feb;6(1):88-97. doi: 10.1016/j.molonc.2011.11.006. Epub 2011 Nov 26. Mol Oncol. 2012. PMID: 22153616 Free PMC article.

9

Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.

Knoop AS, Lænkholm AV, Jensen MB, Nielsen KV, Andersen J, Nielsen D, Ejlertsen B; Danish Breast Cancer Cooperative Group. Knoop AS, et al. Among authors: jensen mb. Eur J Cancer. 2014 May;50(8):1412-21. doi: 10.1016/j.ejca.2014.02.022. Epub 2014 Mar 24. Eur J Cancer. 2014. PMID: 24675287 Clinical Trial.

10

Reduced risk of axillary lymphatic spread in triple-negative breast cancer.

Holm-Rasmussen EV, Jensen MB, Balslev E, Kroman N, Tvedskov TF. Holm-Rasmussen EV, et al. Among authors: jensen mb. Breast Cancer Res Treat. 2015 Jan;149(1):229-36. doi: 10.1007/s10549-014-3225-y. Epub 2014 Dec 9. Breast Cancer Res Treat. 2015. PMID: 25488719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

598 results

Search Page

Filters